These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 32592092)
1. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression. Ng CW; Jiang AA; Toh EMS; Ng CH; Ong ZH; Peng S; Tham HY; Sundar R; Chong CS; Khoo CM Int J Colorectal Dis; 2020 Aug; 35(8):1501-1512. PubMed ID: 32592092 [TBL] [Abstract][Full Text] [Related]
2. Suppressive effects of metformin on colorectal adenoma incidence and malignant progression. Deng M; Lei S; Huang D; Wang H; Xia S; Xu E; Wu Y; Zhang H Pathol Res Pract; 2020 Feb; 216(2):152775. PubMed ID: 31818523 [TBL] [Abstract][Full Text] [Related]
3. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis. Meng F; Song L; Wang W J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076 [No Abstract] [Full Text] [Related]
4. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis. Liu F; Yan L; Wang Z; Lu Y; Chu Y; Li X; Liu Y; Rui D; Nie S; Xiang H Oncotarget; 2017 Feb; 8(9):16017-16026. PubMed ID: 27926481 [TBL] [Abstract][Full Text] [Related]
5. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis. Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047 [TBL] [Abstract][Full Text] [Related]
6. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis. Tseng CH Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547 [TBL] [Abstract][Full Text] [Related]
7. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis. Wang Q; Shi M Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743 [TBL] [Abstract][Full Text] [Related]
8. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis. Nie Z; Zhu H; Gu M Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666 [TBL] [Abstract][Full Text] [Related]
9. Additively protective effects of vitamin D and calcium against colorectal adenoma incidence, malignant transformation and progression: A systematic review and meta-analysis. Huang D; Lei S; Wu Y; Weng M; Zhou Y; Xu J; Xia D; Xu E; Lai M; Zhang H Clin Nutr; 2020 Aug; 39(8):2525-2538. PubMed ID: 31784301 [TBL] [Abstract][Full Text] [Related]
10. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies. Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573 [TBL] [Abstract][Full Text] [Related]
11. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis. He XK; Su TT; Si JM; Sun LM Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616 [TBL] [Abstract][Full Text] [Related]
12. Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis. Hou YC; Hu Q; Huang J; Fang JY; Xiong H Oncotarget; 2017 Jan; 8(5):8843-8853. PubMed ID: 27903961 [TBL] [Abstract][Full Text] [Related]
13. Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis. Yang WT; Yang HJ; Zhou JG; Liu JL Int J Colorectal Dis; 2020 Nov; 35(11):2117-2131. PubMed ID: 32720184 [TBL] [Abstract][Full Text] [Related]
14. The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer. Ala M Curr Diabetes Rev; 2022; 18(8):e051121197762. PubMed ID: 34749618 [TBL] [Abstract][Full Text] [Related]
15. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Zhang ZJ; Zheng ZJ; Kan H; Song Y; Cui W; Zhao G; Kip KE Diabetes Care; 2011 Oct; 34(10):2323-8. PubMed ID: 21949223 [TBL] [Abstract][Full Text] [Related]
16. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus. Tarhini Z; Manceur K; Magne J; Mathonnet M; Jost J; Christou N Sci Rep; 2022 Jul; 12(1):12374. PubMed ID: 35859114 [TBL] [Abstract][Full Text] [Related]
17. Metformin usage and the risk of colorectal cancer: a national cohort study. Lee JW; Choi EA; Kim YS; Kim Y; You HS; Han YE; Kim HS; Bae YJ; Kim J; Kang HT Int J Colorectal Dis; 2021 Feb; 36(2):303-310. PubMed ID: 32968891 [TBL] [Abstract][Full Text] [Related]
18. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus. Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195 [TBL] [Abstract][Full Text] [Related]
19. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients. Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714 [TBL] [Abstract][Full Text] [Related]
20. Metformin increases cancer specific survival in colorectal cancer patients-National cohort study. Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Urbonas V; Smailyte G Cancer Epidemiol; 2019 Oct; 62():101587. PubMed ID: 31491730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]